In the Philippines, too, reform is on the way and the business conditions are evolving fast. As a local medium-size player,
you stand a chance to gain benefits from these reshufflings, as your local knowledge will always prime. Indeed, companies
like United Laboratories, a leader in the Philippines, have grown from modest players to giants with increasingly global outlooks.
And, all these companies conserve the benefits of market recognition and local knowledge that are indispensable to succeed
in challenging markets such as Southeast Asia's.
The changing shape and business conditions in the Southeast Asian pharmaceutical industry should in turn open avenues of cooperation
between US or European companies and Asian players. Amongst similar companies by size and profiles, there are plenty of synergies
to be developed. With local companies often being able to tap into consumer pools ranging from 25 to 220 million people for
one country, and up to potentially 520 million consumers across the region, market prospects are appealing, even when considering
the low disposable-income levels. Should a western company be the holder of an innovative technology that can be easily transposed
in Asia, and many success stories could blossom and thrive. The ethos and business abilities of local players, from the leaders
through to the challengers, are very convincing. Their faith in the market is genuine and their will to succeed is fundamental.
Like-minded business people from across the world always find subjects of common interests. At the time of over-focus on China
and India, it is well worth to step back, take some prospective, and see the opportunities waiting to be realized in Indonesia,
Malaysia, Thailand, the Philippines, and Singapore.
This report was prepared by Executive Country Reviews. Authors are Gilles Valentin firstname.lastname@example.org
Emmanuelle Berthemet email@example.com
Marco Parigi firstname.lastname@example.org
Amicie de Bodinat email@example.com
and Yaz Yazicioglu firstname.lastname@example.org